Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

9.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.3K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

130
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
130
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

153
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
153
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

2.9K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.9K
Factors Affecting Drug Biotransformation: Biological01:19

Factors Affecting Drug Biotransformation: Biological

252
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
252

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association Between Statin Initiation and Myasthenia Gravis Crisis.

Journal of clinical neurology (Seoul, Korea)Ā·2026
Same author

GLP-1 Receptor Agonists for Weight Loss and Risk of Major Safety Outcomes: A Multicentre Cohort Study.

Diabetes, obesity & metabolismĀ·2026
Same author

Effect of anemia developed after ruxolitinib initiation on adverse outcomes in patients with myelofibrosis: a nationwide cohort study.

Blood cancer journalĀ·2026
Same author

Systemic atopy and upper-airway disease define susceptibility to incident asthma after COVID-19 in Korea.

Nature communicationsĀ·2026
Same author

Computational Insights Into Smart Bioelectronics in Digital Health Care (2020-2024): Topic Modeling Study.

JMIR medical informaticsĀ·2026
Same author

A Practical Approach to Assessing the Completeness of Electronic Health Records for Medical Research: Data Quality Study.

JMIR medical informaticsĀ·2026

Related Experiment Video

Updated: Sep 16, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

587

Predicting Drug-Side Effect Relationships From Parametric Knowledge Embedded in Biomedical BERT Models:

Woohyuk Jeon1, Minjae Park1, Doyeon An1

  • 1Department of Computer Engineering, College of IT Convergence, Gachon University, AIĀ·Engineering Building, 317A, 1342 Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Seongnam, 13120, Republic of Korea, 82 010-9012-9364, 82 031-750-5333.

JMIR Medical Informatics
|July 10, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces a novel method using biomedical BERT models to predict unknown drug-side effect relationships, outperforming traditional models. The approach demonstrates high accuracy and practical applicability in managing adverse drug reactions.

Keywords:
ADR predictionBERTBidirectional Encoder Representations from TransformersNLPadverse drug reactiondrug-side effect relationshipnatural language processingword embedding

More Related Videos

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

692
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K

Related Experiment Videos

Last Updated: Sep 16, 2025

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

587
Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
03:14

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

692
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.8K

Area of Science:

  • Biomedical Informatics
  • Natural Language Processing
  • Pharmacovigilance

Background:

  • Adverse drug reactions (ADRs) present significant patient health risks.
  • Traditional word embedding models like Word2Vec struggle with biomedical text specificity.
  • BERT models show promise but require further research for predicting unknown drug-side effect relationships.

Purpose of the Study:

  • To predict novel drug-side effect relationships using parametric knowledge from biomedical BERT models.
  • To leverage embedding vector similarities of known relationships for enhanced prediction.
  • To identify potential drug-side effect candidates with unknown causal mechanisms.

Main Methods:

  • Utilized 158,096 drug-side effect pairs from the SIDER database to create an adjacency matrix.
  • Calculated cosine similarity between drug and side effect word embedding vectors.
  • Computed relation scores for 8,235,435 drug-side effect pairs and evaluated using Area Under the Curve (AUC).

Main Results:

  • The clagator/biobert_v1.1 model achieved an AUC of 0.915, surpassing Word2Vec (AUC 0.848).
  • BERT models pretrained on biomedical corpora outperformed vanilla BERT (AUC 0.857).
  • External validation with FDA Adverse Event Reporting System data showed high statistical significance (P<.001, OR=4.822).

Conclusions:

  • A novel method for predicting drug-side effect relationships using pretrained biomedical language models was developed.
  • BERT-based models excel in predicting drug-side effect relationships due to contextual understanding.
  • The approach demonstrates practical utility for predicting and managing ADRs.